Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jun-Lin Guan, Anna Katharina Simon, Mark Prescott, Javier A. Menendez, Fei Liu, Fen Wang, Chenran Wang, Ernst Wolvetang, Alejandro Vazquez-Martin & Jue Zhang. (2013) Autophagy in stem cells. Autophagy 9:6, pages 830-849.
Read now
Read now
Shan Zhu, Lizhi Cao, Yan Yu, Liangchun Yang, Minghua Yang, Ke Liu, Jun Huang, Rui Kang, Kristen M. Livesey & Daolin Tang. (2013) Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy 9:3, pages 317-327.
Read now
Read now
Angelo Michele Carella, Germana Beltrami, Gianmatteo Pica, Andrea Carella & Gioacchino Catania. (2012) Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia. Leukemia & Lymphoma 53:7, pages 1409-1411.
Read now
Read now
Articles from other publishers (53)
Elahe Razmara Lak, Gholamhossein TamaddonMani RamziReza RanjbaranElham Abedi & Sedigheh Sharifzadeh. (2023) The mRNA Expression of PTEN, LEF1, JAK3, LC3 and p62/SQSTM1
Genes in Patients with Chronic Myeloid Leukemia. Cardiovascular & Hematological Agents in Medicinal Chemistry 21:1, pages 67-76.
Crossref
Crossref
Anowarul Islam, Zeeshan Shaukat, Rashid Hussain & Stephen L. Gregory. (2022) One-Carbon and Polyamine Metabolism as Cancer Therapy Targets. Biomolecules 12:12, pages 1902.
Crossref
Crossref
Berfin Tugba TURAK. (2022) PHYTOCHEMICAL CONSTITUENTS AND ANTILEUKEMIC EFFECTS OF JUNIPERUS OXYCEDRUS EXTRACT. Biotechnologia Acta 15:5, pages 64-70.
Crossref
Crossref
Ying Xu, Jiawei Lu, Yinbing Tang, Wenjie Xie, Heteng Zhang, Beibei Wang, Shouliang Zhang, Wenji Hou, Chen Zou, Pengcheng Jiang & Wenbo Zhang. (2022) RETRACTED: PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages. Cancer Letters 529, pages 19-36.
Crossref
Crossref
Ali Salimi-Jeda, Soad Ghabeshi, Zeinab Gol Mohammad pour, Ehsan Ollah Jazaeri, Mehrdad Araiinejad, Farzaneh Sheikholeslami, Mohsen Abdoli, Mahdi Edalat & Asghar Abdoli. (2022) Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy. Cancer Treatment and Research Communications 30, pages 100512.
Crossref
Crossref
S. Baykal-Köse, H. Efe & Z. Yüce. (2021) Autophagy Does Not Contribute to TKI Response in a Imatinib-Resistant Chronic Myeloid Leukemia Cell Line. Molecular Biology 55:4, pages 573-579.
Crossref
Crossref
Yammy Yung, Emily Lee, Hiu-Tung Chu, Pui-Kwan Yip & Harinder Gill. (2021) Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms. International Journal of Molecular Sciences 22:2, pages 659.
Crossref
Crossref
Chuquan Shang, Bardes Hassan, Moinul Haque, Yuqi Song, Jing Li, Dongzhe Liu, Eva Lipke, Will Chen, Sylvie Giuriato & Raymond Lai. (2021) Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent. Cancers 13:2, pages 181.
Crossref
Crossref
Christopher C. Donnell, Richard L. Walton & Marco Carrozzo. (2021) The blue palate—A case series of imatinib-related oral pigmentation and literature review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131:1, pages 49-61.
Crossref
Crossref
Fabien Muselli, Jean-François Peyron & Didier Mary. (2019) Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia. International Journal of Molecular Sciences 20:22, pages 5616.
Crossref
Crossref
Tavakol, Ashrafizadeh, Deng, Azarian, Abdoli, Motavaf, Poormoghadam, Khanbabaei, Afshar, Mandegary, Pardakhty, Yap, Mohammadinejad & Kumar. (2019) Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems. Biomolecules 9:10, pages 530.
Crossref
Crossref
Mohammad Houshmand, Giorgia Simonetti, Paola Circosta, Valentina Gaidano, Alessandro Cignetti, Giovanni Martinelli, Giuseppe Saglio & Robert Peter Gale. (2019) Chronic myeloid leukemia stem cells. Leukemia 33:7, pages 1543-1556.
Crossref
Crossref
Mojgan Djavaheri-Mergny, Sylvie Giuriato, Mario P. Tschan & Magali Humbert. (2019) Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma. Cells 8:2, pages 103.
Crossref
Crossref
Lindsay WildeKatherina TansonJoseph CurryUbaldo Martinez-Outschoorn. (2018) Autophagy in cancer: a complex relationship. Biochemical Journal 475:11, pages 1939-1954.
Crossref
Crossref
Han Zhang. (2018) Targeting autophagy in lymphomas: a double-edged sword?. International Journal of Hematology 107:5, pages 502-512.
Crossref
Crossref
Sujuan Guo, Kevin J. Pridham, Ching-Man Virbasius, Bin He, Liqing Zhang, Hanne Varmark, Michael R. Green & Zhi Sheng. (2018) A large-scale RNA interference screen identifies genes that regulate autophagy at different stages. Scientific Reports 8:1.
Crossref
Crossref
Cagla Kayabasi, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Aycan Asik, Sunde Yilmaz Susluer, Cigir Biray Avci, Guray Saydam & Cumhur Gunduz. (2017) Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia. Gene 637, pages 173-180.
Crossref
Crossref
Guilhem Bousquet, Morad El Bouchtaoui, Tan Sophie, Christophe Leboeuf, Cédric de Bazelaire, Philippe Ratajczak, Sylvie Giacchetti, Anne de Roquancourt, Philippe Bertheau, Laurence Verneuil, Jean-Paul Feugeas, Marc Espié & Anne Janin. (2017) Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer. Oncotarget 8:21, pages 35205-35221.
Crossref
Crossref
Biqing Han, Yanmin Zhao, Yu Lin, Shan Fu, Limengmeng Wang, Mingming Zhang, Ruxiu Tie, Binsheng Wang, Yi Luo, Lizhen Liu, Jian Yu & He Huang. (2017) Hydroxychloroquine sensitizes chronic myeloid leukemia cells to Vγ9Vδ2 T cell-mediated lysis independent of autophagy. International Journal of Oncology 50:5, pages 1810-1820.
Crossref
Crossref
L. V. Adamyan, A. V. Asaturova, A. A. Stepanian & A. Yu. Popryadukhin. (2017) The role of the mechanisms of anoikis and autophagy in the pathogenesis of endometriosis (a review). Problemy reproduktsii 23:4, pages 81.
Crossref
Crossref
Zhiwu Dong, Shuang Liang, Jun Hu, Weiyun Jin, Qilin Zhan & Kewen Zhao. (2016) Autophagy as a target for hematological malignancy therapy. Blood Reviews 30:5, pages 369-380.
Crossref
Crossref
A Ruiz, S Rockfield, N Taran, E Haller, R W Engelman, I Flores, P Panina-Bordignon & M Nanjundan. (2016) Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis. Cell Death & Disease 7:1, pages e2059-e2059.
Crossref
Crossref
Sunad Rangarajan, Ashish Kurundkar, Deepali Kurundkar, Karen Bernard, Yan Y. Sanders, Qiang Ding, Veena B. Antony, Jianhua Zhang, Jaroslaw Zmijewski & Victor J. Thannickal. (2016) Novel Mechanisms for the Antifibrotic Action of Nintedanib. American Journal of Respiratory Cell and Molecular Biology 54:1, pages 51-59.
Crossref
Crossref
Géraldine Mitou, Julie Frentzel, Aurore Desquesnes, Sophie Le Gonidec, Talal AlSaati, Isabelle Beau, Laurence Lamant, Fabienne MeggettoEstelle EspinosPatrice Codogno, Pierre Brousset & Sylvie Giuriato. (2015) Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma. Oncotarget 6:30, pages 30149-30164.
Crossref
Crossref
Hyung-Ok Lee, Aladdin Mustafa, Gary R. Hudes & Warren D. Kruger. (2015) Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells. PLOS ONE 10:7, pages e0131464.
Crossref
Crossref
Stephanie M. TortorellaAndrew HungTom C. Karagiannis. (2015) The Implication of Cancer Progenitor Cells and the Role of Epigenetics in the Development of Novel Therapeutic Strategies for Chronic Myeloid Leukemia. Antioxidants & Redox Signaling 22:16, pages 1425-1462.
Crossref
Crossref
Ke Yang & Li-wu Fu. (2015) Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review. Critical Reviews in Oncology/Hematology 93:3, pages 277-292.
Crossref
Crossref
Justin S. Gundara, JingTing Zhao, Anthony J. Gill, James C. Lee, Leigh Delbridge, Bruce G. Robinson, Catriona McLean, Jonathan Serpell & Stan B. Sidhu. (2014)
Noncoding
RNA
blockade of autophagy is therapeutic in medullary thyroid cancer
. Cancer Medicine 4:2, pages 174-182.
Crossref
Crossref
Xuejun Jiang, Michael Overholtzer & Craig B. Thompson. (2015) Autophagy in cellular metabolism and cancer. Journal of Clinical Investigation 125:1, pages 47-54.
Crossref
Crossref
N Hasima & B Ozpolat. (2014) Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death & Disease 5:11, pages e1509-e1509.
Crossref
Crossref
Mihajlo Bosnjak, Biljana Ristic, Katarina Arsikin, Aleksandar Mircic, Violeta Suzin-Zivkovic, Vladimir Perovic, Andrija Bogdanovic, Verica Paunovic, Ivanka Markovic, Vladimir Bumbasirevic, Vladimir Trajkovic & Ljubica Harhaji-Trajkovic. (2014) Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death. PLoS ONE 9:4, pages e94374.
Crossref
Crossref
Donglei Liu, Yang Yang & Song Zhao. (2014) Autophagy facilitates the EGFR-TKI acquired resistance of non-small-cell lung cancer cells. Journal of the Formosan Medical Association 113:3, pages 141-142.
Crossref
Crossref
Motohiko Satoh, Yukitoshi Takemura, Hironobu Hamada, Yoshitaka Sekido & Shunichiro Kubota. (2013) EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy. Cancer Cell International 13:1.
Crossref
Crossref
Robin L. Macintosh & Kevin M. Ryan. (2013) Autophagy in tumour cell death. Seminars in Cancer Biology 23:5, pages 344-351.
Crossref
Crossref
Izabela Dereń-Wagemann, Marek Kiełbiński & Kazimierz Kuliczkowski. (2013) Autofagia – proces o dwóch obliczach. Acta Haematologica Polonica 44:4, pages 383-391.
Crossref
Crossref
Niharika Sinha, Subhadip Mukhopadhyay, Durgesh Nandini Das, Prashanta Kumar Panda & Sujit K. Bhutia. (2013) Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncology 49:9, pages 854-862.
Crossref
Crossref
Giuseppe Saglio & Carmen FavaDavid Marin & Antonia Rotolo. 2013. The Treatment of Chronic Myeloid Leukemia. The Treatment of Chronic Myeloid Leukemia
98
112
.
Jie Han, Wen Hou, Caisheng Lu, Leslie A. Goldstein, Donna B. Stolz, Simon C. Watkins & Hannah Rabinowich. (2013) Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation. Journal of Biological Chemistry 288:28, pages 20315-20325.
Crossref
Crossref
Tomasz Stoklosa, Eliza Glodkowska-Mrowka, Grazyna Hoser, Magdalena Kielak, Ilona Seferynska & Pawel Wlodarski. (2013) Diverse mechanisms of mTOR activation in chronic and blastic phase of chronic myelogenous leukemia. Experimental Hematology 41:5, pages 462-469.
Crossref
Crossref
Ahmad Hamad, Zeyad Sahli, Maya El Sabban, Maha Mouteirik & Rihab Nasr. (2013) Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells. Stem Cells International 2013, pages 1-12.
Crossref
Crossref
Jianzhou Cui & Han-Ming Shen. 2013. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
175
203
.
Cristina Trejo-Solís, Dolores Jimenez-Farfan, Sara Rodriguez-Enriquez, Francisca Fernandez-Valverde, Arturo Cruz-Salgado, Lena Ruiz-Azuara & Julio Sotelo. (2012) Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation. BMC Cancer 12:1.
Crossref
Crossref
Chi-Iou Lin, Edward E. Whang, Jochen H. Lorch & Daniel T. Ruan. (2012) Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer. Surgery 152:6, pages 1142-1149.
Crossref
Crossref
Katelin N. Townsend, Luke R. K. Hughson, Katrin Schlie, Vincent I. Poon, Ashley Westerback & Julian J. Lum. (2012) Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity. Immunological Reviews 249:1, pages 176-194.
Crossref
Crossref
A M Carella, G Beltrami, G Catania, G Pica, C Ghiggi, A Garuti & A Carella. (2012) Inhibition of autophagy with clarithromycin: a new strategy to enhance sensitivity of CML stem cells to tyrosine kinase inhibitors. Leukemia Supplements 1:S2, pages S49-S50.
Crossref
Crossref
A.L. Swampillai, P. Salomoni & S.C. Short. (2012) The Role of Autophagy in Clinical Practice. Clinical Oncology 24:6, pages 387-395.
Crossref
Crossref
Valentina Kovaleva, Rodrigo Mora, Yoon Jung Park, Christoph Plass, Abhilash I. Chiramel, Ralf Bartenschlager, Hartmut Döhner, Stephan Stilgenbauer, Armin Pscherer, Peter Lichter & Martina Seiffert. (2012)
miRNA-130a Targets
ATG2B
and
DICER1
to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells
. Cancer Research 72:7, pages 1763-1772.
Crossref
Crossref
Huseyin Atakan Ekiz, Geylani Can & Yusuf Baran. (2012) Role of autophagy in the progression and suppression of leukemias. Critical Reviews in Oncology/Hematology 81:3, pages 275-285.
Crossref
Crossref
Kyeong Sook Choi. (2012) Autophagy and cancer. Experimental & Molecular Medicine 44:2, pages 109.
Crossref
Crossref
Versha Banerji & Spencer B. Gibson. (2012) Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies. International Journal of Cell Biology 2012, pages 1-9.
Crossref
Crossref
Nicholas J. Donato. (2011) Bcr-Abl adds another twist to cell fate. Blood 118:10, pages 2646-2647.
Crossref
Crossref
Cassius Carvalho Torres-Pereira. (2011) Are we ready to blame imatinib for palatal pigmentation?. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 112:3, pages 287.
Crossref
Crossref
G. Vignir Helgason, Maria Karvela & Tessa L. Holyoake. (2011) Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 118:8, pages 2035-2043.
Crossref
Crossref